Watchlist for April 2, 2007

It looks like I didn't miss much on Thursday & Friday. Both the Nasdaq and S&P 500 traded between their 50-day moving averages and the breakout points of their recent W-bottoms. I'll be watching for solid moves across of those areas this week. Here's the S&P chart:

On Today's Calendar:

10:00 -- ISM Index

More Calendars: U.S. Earnings | Conf. Calls | Surprises | IPO | Economic

Potential swing trades:

See one of the recent 'Chart Reading' posts for some potential swing candidates.

Potential day trades:

(From Briefing.com)

Gapping Down

Gapping down on weak earnings/guidance: MTB -7.6%, ADST -5.5%, VYYO -4.4%, POP -3.7%, TTM -2.8%... Down in sympathy on MTB warning, which cited impact to Alt-A loans: NFI -7.0%, LEND -2.5%... Other news: MO -23.9% (Kraft spin-off effective today), ADP -10.1% (Broadridge Financial unit spin-off effective today), GRZ -3.1% (profit-taking after last week's gap up).

Gapping Up

Gapping up on strong earnings/guidance: IDSA +9.0%, IIG +8.6%... Other news: VYYO +12.5 (secures additional funding from Goldman Sachs), FFHL +10.1% (initiated with a Buy at Maxim), Gapping up on strong earnings/guidance: XFN +42.3%, BDCO +6.1%, CALM +6.0%, BAMM +5.0%... M&A: GISX +47.4% (to be acquired by XRX for $29/share), FDC +22.1% (to be acquired by KKR for $34/share in cash), QVDX +8.6% (announces sale of co for $3.15/share), MEH +5.9% (Air Tran increases tender offer to MEH shareholders to $15.00/share), TRB +2.0% (confirms it will go private for $34/share)... Other news: TI +10.4% (AT&T in negotiations for investment in TI), AVII +8.2% (follow-through momentum from Friday), ABY +6.4% (positive Barron's story), TAYD +6.1% (earthquake struck the South Pacific with a magnitude of 8.0 causing a Tsunami to hit Solomons), JSDA +6.0% (appoints Peter Burns as Senior Executive VP of Sales and Marketing), PDRT +5.1% (announces it successfully completes PID-system trial in Travis Peak Formation), KRY +4.1% (says co is in final stages of environmental permitting for Las Cristinas project), STEM +4.0% (British team grows human heart valve from stem cells - The Guardian; also Prudential comments on stem cell legislation), CEPH +3.7% (receives FDA approvable letter for Nuvigil), DNDN +3.6% (follow-through momentum from Friday), JADE +3.4% (follow-through momentum from Friday).